- Home
- AYRO vs ACON Comparison
AYRO vs ACON Comparison
Compare AYRO & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYRO
- ACON
- Stock Information
- Founded
- AYRO 2017
- ACON 2008
- Country
- AYRO United States
- ACON United States
- Employees
- AYRO N/A
- ACON N/A
- Industry
- AYRO Telecommunications Equipment
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- AYRO Consumer Discretionary
- ACON Technology
- Exchange
- AYRO Nasdaq
- ACON Nasdaq
- Market Cap
- AYRO 4.3M
- ACON 4.8M
- IPO Year
- AYRO N/A
- ACON 2022
- Fundamental
- Price
- AYRO $0.49
- ACON $7.10
- Analyst Decision
- AYRO
- ACON Buy
- Analyst Count
- AYRO 0
- ACON 2
- Target Price
- AYRO N/A
- ACON $481.00
- AVG Volume (30 Days)
- AYRO 84.7K
- ACON 50.1K
- Earning Date
- AYRO 05-23-2025
- ACON 05-23-2025
- Dividend Yield
- AYRO N/A
- ACON N/A
- EPS Growth
- AYRO N/A
- ACON N/A
- EPS
- AYRO N/A
- ACON N/A
- Revenue
- AYRO $63,777.00
- ACON $45,724.00
- Revenue This Year
- AYRO N/A
- ACON $212.31
- Revenue Next Year
- AYRO N/A
- ACON N/A
- P/E Ratio
- AYRO N/A
- ACON N/A
- Revenue Growth
- AYRO N/A
- ACON N/A
- 52 Week Low
- AYRO $0.38
- ACON $6.20
- 52 Week High
- AYRO $1.29
- ACON $3,500.42
- Technical
- Relative Strength Index (RSI)
- AYRO 45.92
- ACON 34.16
- Support Level
- AYRO $0.44
- ACON $6.80
- Resistance Level
- AYRO $0.67
- ACON $7.54
- Average True Range (ATR)
- AYRO 0.05
- ACON 0.58
- MACD
- AYRO 0.00
- ACON 3.31
- Stochastic Oscillator
- AYRO 21.74
- ACON 42.86
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.